Industry Conference

As AI moves from digital clouds to factory floors, a new exhibition in Düsseldorf aims to bridge global hardware suppliers with European industrial buyers.

As iMDx prepares for the BTIG Kidney Health Forum, the diagnostics challenger is leveraging European clinical data to disrupt the post-transplant testing market.

Odyssey Therapeutics is testing a novel combination therapy for ulcerative colitis, aiming to break the therapeutic ceiling that limits current IBD treatments.

Phathom Pharmaceuticals is using predictive modeling to prove its premium-priced drug VOQUEZNA can beat generic PPIs by preventing long-term complications.

Ahead of SPS 2026, Phoenix Contact is shifting industrial automation by decoupling control logic from hardware and racing to meet CRA cybersecurity mandates.

As bird-safe mandates and energy codes reshape American skylines, Turkish industrial giant Sisecam aims to build the sustainable facades of tomorrow.

As global supply chains fracture, Chinese manufacturers are flocking to Uzbekistan's textile fairs to build a new Silk Road manufacturing powerhouse.

As The Business Times launches an exclusive luxury symposium, the move highlights Singapore's shift from passive wealth hub to global tastemaker.

As AI moves from the cloud to the factory floor, enterprises face a billion-dollar question: how to buy hardware that won't be obsolete in six months.

Jack Patterson examines how new off-the-shelf CAR T-cell therapy and optimized monoclonal antibodies could disrupt the multiple sclerosis treatment paradigm.

Gary Clark explores the business of executive speaking competitions, analyzing how WILDx VOLTARA monetizes thought leadership and networking in Beverly Hills.

Athenian Group's LA28 platform reveals how boutique consultancies use AI and digital tools to solve local government's biggest infrastructure hurdles.

As generative AI hype fades, multinational giants are pivoting to agentic decision intelligence to automate global supply chains and reshape white-collar work.

As institutional capital slows, mega-funds turn to independent advisors. Tech platforms like CAIS are building the pipes for this trillion-dollar pivot.

Ahead of a critical 2027 data readout, Moleculin pitches a breakthrough leukemia drug while navigating a precarious financial runway.

As Japan tackles a demographic crunch, Taiwanese automation firm ICP DAS brings its protocol gateways and redundant I/O to Osaka to modernize factories.

As AI moves from chatbots to factory floors, Taiwan is leveraging its semiconductor dominance to capture the lucrative Physical AI software stack.

As Chile Wine Fest debuts in Miami, producers are battling tariffs and 'value' stereotypes to reposition their wines and pisco for the luxury market.

As regional banks navigate deposit wars and CRE risks, Citizens Financial CFO Aunoy Banerjee prepares to detail the ROI of the bank's AI-driven transformation.

As retail investors flood the private markets, ADISA’s inaugural awards highlight the gatekeepers bringing institutional rigor to alternative investments.